The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.
stock
-
-
Published on Feb 27, 2026 Share Investorideas.com (Investorideas.com Newswire) a top 100 rated investment site for retail Investors following…
-
The Neutron rocket was expected to have its debut last year. Now, it’s projected to launch at the end of 2026.
-
The company, which makes hyperconverged infrastructure including storage offerings, is partnering with AMD and betting that AI customers want flexible ecosystems.
-
Investment
Biotech Stock Edesa Biotech (Nasdaq:EDSA) Gains on News of Additional Positive Results from Phase 3 Paridiprubart Study
Published on Feb 24, 2026 Share (Investorideas.com Newswire) a go-to platform for big investing ideas, including biotech…
-
Infosys shares looked set to rally after collaboration with Anthropic, just after the AI company had helped trigger a sharp selloff in the IT-consultant sector.
-
Stocks
Is the stock market open tomorrow for Presidents Day? Will USPS, FedEx and UPS make deliveries?
Here’s how trading hours and other services will be affected on the federal holiday, which falls on Monday, Feb. 16, this year.
-
Stocks
Amazon’s stock just clinched its worst losing streak in nearly 20 years. It’s giving investors AWS déjà vu.
As shares of Amazon deepen into a bear market, investors are once again weighing if the company’s spending plans will pay off.
-
The athleisure company’s stock falls after more “see-through” complaints surfaced about a new leggings line.
-
Stocks
Hims & Hers stock poised for heavy losses after quick U-turn on plan for oral Wegovy competitor
Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk’s Wegovy oral weight-loss drug.
